King A, Bathgate T, Phillips I. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. Clin Microbiol Infect. 2002;8:85 92. 145. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM, Kaye D. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000; 102:2842 2848. 146. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med. 1999;20:303 316, viii. 147. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, Bland LA, Jarvis WR. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995;172:993 1000. 148. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staph- ylococcus aureus. Arch Intern Med. 1998;158:182 189. 149. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attrib- utable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol. 1999;20:396 401. 150. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bac- teremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26:1127 1133. 151. Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML; for the SENTRY Participants Group. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and anti- microbial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Sur- veillance Program. Diagn Microbiol Infect Dis. 1999;33:283 297. 152. 